Starling Oncology, Inc. Defined Contribution Plan, Cost
Starling Oncology, Inc. (DFPH) reported Defined Contribution Plan, Cost of $1.38 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-12
- Starling Oncology, Inc. defined contribution plan, cost for fiscal 2025 was $1.38M, a 5.60% decline from fiscal 2024.
- Starling Oncology, Inc. defined contribution plan, cost for fiscal 2024 was $1.47M, a 15.26% increase from fiscal 2023.
- Starling Oncology, Inc. defined contribution plan, cost for fiscal 2023 was $1.27M, a 14.71% increase from fiscal 2022.
- Starling Oncology, Inc. defined contribution plan, cost for fiscal 2022 was $1.11M, a 40.79% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.38M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $1.47M 10-K · filed 2026-03-12 | $1.38M 10-K · filed 2025-03-26 |
| 2023-12-31 | $1.27M 10-K · filed 2025-03-26 | |
| 2022-12-31 | $1.11M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $787.00K 10-K · filed 2023-03-16 | |
| 2020-12-31 | $504.00K 10-K · filed 2022-03-11 |